AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
Metrics to compare | ACOUS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACOUSPeersSector | |
---|---|---|---|---|
P/E Ratio | −5.0x | −9.6x | −0.5x | |
PEG Ratio | −0.25 | −0.20 | 0.00 | |
Price/Book | 15.8x | 6.6x | 2.6x | |
Price / LTM Sales | 8.0x | 42.2x | 3.3x | |
Upside (Analyst Target) | 169.5% | 12.6% | 42.8% | |
Fair Value Upside | Unlock | 8.2% | 6.5% | Unlock |